| Bioactivity | INCB3619 is a selective and orally active ADAM inhibitor with IC50 of 22 nM and 14 nM for ADAM10 and ADAM17, respectively. INCB3619 has anti-tumor activity[1]. |
| Invitro | INCB3619 (0-0.25 μM, 96 h) 可以抑制 heregulin 依赖性 HER3-Akt 通路,但不能抑制 A549 细胞中的 ERK 活性,可诱导 A549 细胞凋亡[1]。 INCB3619 (0-10 μM, 72 h) 可以抑制 EGFR 自分泌细胞系 NCI-H1666 中的 EGFR 配体信号传导,并可与其他抗 EGFR 药物,如吉非替尼联合使用[1]。INCB3619 (2 µM) 抑制 NCI-H166 细胞中 ERK1/2 的表达,使其对吉非替尼 (Gefitinib,HY-50895) 敏感[1]。 Apoptosis Analysis[1]. Cell Line: |
| Name | INCB3619 |
| CAS | 791826-72-7 |
| Formula | C22H27N3O5 |
| Molar Mass | 413.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |